Advertisement

Topics

Colorectal Cancer – Pipeline Review, H1 2018 – ResearchAndMarkets.com

18:04 EDT 28 Sep 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer – Pipeline Review, H1 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, … Continue reading

Cet article Colorectal Cancer – Pipeline Review, H1 2018 – ResearchAndMarkets.com est apparu en premier sur Biotech 365.

Original Article: Colorectal Cancer – Pipeline Review, H1 2018 – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Colorectal Cancer – Pipeline Review, H1 2018 – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...